SynthesisCurrent oncology (Toronto, Ont.)2022

Is There a Survival Benefit of Adjuvant Chemotherapy in Stage IC1 Epithelial Ovarian Cancer Patients? A Meta-Analysis.

Vasilios Pergialiotis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.